Search reports.
India Drug Delivery Devices Market Growth & Forecast [2031]
Get free sample report Request for Customiztion Buy Now

India Drug Delivery Devices Market Growth & Forecast [2031]

Segments - India Drug Delivery Devices Market by Route of Administration (Topical, Injectable, Ocular, and Others), Applications (Infectious diseases, Cardiovascular cancer, Diabetes, and Others), and End-users (Ambulatory Surgical Centres, Hospitals, and Others), and Country – India Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1806 | 4.8 Rating | 76 Reviews | 195 Pages | Format : PDF Excel PPT

Report Description


The India Drug Delivery Devices Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 5.5% during the forecast period, 2023 – 2031. Growth of the market is attributed to the increasing funding from government & private organization, rising number of development & research activities, rise in technological advancement, and unhealthy lifestyle.

The delivery of a drug and therapeutic is done by specialized tools from a specific route of administration like drug delivery devices. As part of one & more medical treatments such devices are used.

India Drug Delivery Devices Market Outlook

The Covid-19 pandemic affected the demand and supply of India drug delivery devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

  • Technological advancement in device sector is projected to boost the market in the coming years.

  • Increasing number of diseases requiring drug delivery is the major factor fueling the market.

  • Rising risk of needlestick injuries is anticipated to restrict the market growth.

  • Lack of awareness about drug delivery devices present a main challenge that can hamper the market expansion during the forecast period.

  • R&D investment and technological advancement drug delivery devices market is projected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the India drug delivery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

India Drug Delivery Devices Market–Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016-2021

Forecast Period

2023-2031

Segmentation

Route of Administration (Topical, Injectable, Ocular, and Others), Applications (Infectious diseases, Cardiovascular cancer, Diabetes, and Others), and End-users (Ambulatory Surgical Centres, Hospitals, and Others)

Country

India

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; 3M Company; Merck & Co.; GlaxoSmithKline PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis AG; and Sarofi

 

Market Segment Insights

 The topical segment accounts for key share of the market

Based on route of administration, the India drug delivery devices market is divided into topical, injectable, ocular, and others. The topical segment accounts for a key share of the market. Growth of the market is attributed to the rising prevalence of cardiac disease, unhealthy lifestyles, rise in elderly population, and increasing number of treatments. However, the injectable segment is anticipated to expand at a rapid pace during the forecast period due to increasing patient pool and increasing preference for minor invasive surgeries.

The diabetes segment is anticipated to hold major market share during the forecast period

Based on applications, the market is fragmented into infectious diseases, cardiovascular cancer, diabetes, and others. The diabetes segment is anticipated to hold the major market share during the forecast period. Growth of the market is attributed to rising population, increasing disposable income, and growing awareness among population. However, the infectious diseases segment is anticipated to expand at a rapid pace during the forecast period due to factors such as international companies attracting many investors, technological innovations in drug delivery devices, and increasing adaptation of stem cell technologies.

India Drug Delivery Devices Market Applications

The hospitals segment accounts for a key share of the market

On the basis of end-users, the India drug delivery devices market is segmented into ambulatory surgical centres, hospitals, and others. The hospitals segment accounts for a key share of the market. Growth of the market is attributed to penetration of drug delivery devices in market and increasing per capita income. However, the ambulatory surgical centres segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing funding from private organizations.

Market outlook

The India drug delivery devices market is anticipated to expand at a high CAGR during the forecast period due to increasing demand for drug delivery devices and rising awareness about health. Growth of the market is attributed to introduction of technological and novel advanced product and smart drug delivery devices for diseases management.

Rapid development in the health sector increased the demand for drug delivery devices in the India. Increasing number of fatal diseases due to changing life style among people is the major factor fueling the market during the forecast period.

Segments

The India drug delivery devices market has been segmented on the basis of

Route of Administration

  • Topical
  • Injectable
  • Ocular
  • Others

Applications

  • Infectious diseases
  • Cardiovascular cancer
  • Diabetes
  • Others

End-users

  • Ambulatory Surgical Centres
  • Hospitals
  • Others

Country

  • India

Key Players

  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • 3M Company
  • Merck & Co.
  • GlaxoSmithKline PLC
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Novartis AG
  • Sarofi

Competitive Landscape

Key players competing in the India drug delivery devices market include Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; 3M Company; Merck & Co.; GlaxoSmithKline PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis AG; and Sarofi

Some of these players are using several market strategies such as product launches, partnerships, merger, capacity expansion, collaborations, and acquisitions to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.

India Drug Delivery Devices Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Drug Delivery Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Drug Delivery Devices Market - Supply Chain
  4.5. Global Drug Delivery Devices Market Forecast
     4.5.1. Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Drug Delivery Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Drug Delivery Devices Market Absolute $ Opportunity
5. Global Drug Delivery Devices Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Drug Delivery Devices Market Size and Volume Forecast by Applications
     5.3.1. Infectious diseases
     5.3.2. Cardiovascular cancer
     5.3.3. Diabetes
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Drug Delivery Devices Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Drug Delivery Devices Market Size and Volume Forecast by End Users
     6.3.1. Ambulatory Surgical Centres
     6.3.2. Hospitals
     6.3.3. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Drug Delivery Devices Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Drug Delivery Devices Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Drug Delivery Devices Demand Share Forecast, 2019-2026
8. North America Drug Delivery Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Drug Delivery Devices Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Drug Delivery Devices Market Size and Volume Forecast by Applications
     8.4.1. Infectious diseases
     8.4.2. Cardiovascular cancer
     8.4.3. Diabetes
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Drug Delivery Devices Market Size and Volume Forecast by End Users
     8.7.1. Ambulatory Surgical Centres
     8.7.2. Hospitals
     8.7.3. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Drug Delivery Devices Demand Share Forecast, 2019-2026
9. Latin America Drug Delivery Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Drug Delivery Devices Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Drug Delivery Devices Market Size and Volume Forecast by Applications
     9.4.1. Infectious diseases
     9.4.2. Cardiovascular cancer
     9.4.3. Diabetes
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Drug Delivery Devices Market Size and Volume Forecast by End Users
     9.7.1. Ambulatory Surgical Centres
     9.7.2. Hospitals
     9.7.3. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Europe Drug Delivery Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Drug Delivery Devices Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Drug Delivery Devices Market Size and Volume Forecast by Applications
     10.4.1. Infectious diseases
     10.4.2. Cardiovascular cancer
     10.4.3. Diabetes
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Drug Delivery Devices Market Size and Volume Forecast by End Users
     10.7.1. Ambulatory Surgical Centres
     10.7.2. Hospitals
     10.7.3. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Drug Delivery Devices Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Applications
     11.4.1. Infectious diseases
     11.4.2. Cardiovascular cancer
     11.4.3. Diabetes
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by End Users
     11.7.1. Ambulatory Surgical Centres
     11.7.2. Hospitals
     11.7.3. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Drug Delivery Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Applications
     12.4.1. Infectious diseases
     12.4.2. Cardiovascular cancer
     12.4.3. Diabetes
     12.4.4. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by End Users
     12.7.1. Ambulatory Surgical Centres
     12.7.2. Hospitals
     12.7.3. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Drug Delivery Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Drug Delivery Devices Market: Market Share Analysis
  13.2. Drug Delivery Devices Distributors and Customers
  13.3. Drug Delivery Devices Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Sun Pharmaceutical Industries Ltd.
     13.4.2. Pfizer Inc.
     13.4.3. 3M Company
     13.4.4. Merck & Co.
     13.4.5. GlaxoSmithKline PLC
     13.4.6. Bayer AG
     13.4.7. F. Hoffmann-La Roche AG
     13.4.8. Johnson

Methodology

Our Clients

General Electric
Deloitte
Siemens Healthcare
sinopec
General Mills
Honda Motor Co. Ltd.
FedEx Logistics
Dassault Aviation